Referenser

  1. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles M, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862-80.

  2. Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47:633-40.

  3. Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7:Cd001829.

  4. Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021;27:1881-95.

  5. Villa A, Menon RS, Kerr AR, De Abreu Alves F, Guollo A, Ojeda D, et al. Proliferative leukoplakia: Proposed new clinical diagnostic criteria. Oral Dis. 2018;24:749-60.

  6. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539-55.

  7. Ramos-García P, González-Moles M, Mello FW, Bagan JV, Warnakulasuriya S. Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta-analysis. Oral Dis. 2021;27:1896-907.

  8. González-Moles M, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021;27:813-28.

  9. González-Moles M, Ramos-García P, Warnakulasuriya S. An appraisal of highest quality studies reporting malignant transformation of oral lichen planus based on a systematic review. Oral Dis. 2021;27:1908-18.

  10. Warnakulasuriya S, Lodi G. Oral potentially malignant disorders: Proceedings from an expert symposium. Oral Dis. 2021;27:1859-61.

  11. Ramos-García P, González-Moles M, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: A systematic review of systematic reviews. Oral Dis. 2021;27:1919-35.

  12. Trager MH, Farmer K, Ulrich C, Basset-Seguin N, Herms F, Geskin LJ, et al. Actinic cheilitis: a systematic review of treatment options. J Eur Acad Dermatol Venereol. 2021;35:815-23.

  13. Nationellt vårdprogram huvud- och halscancer [Available from: https://cancercentrum.se/samverkan/cancerdiagnoser/huvud-och-hals/vardprogram/

  14. Du G, Patzelt S, van Beek N, Schmidt E. Mucous membrane pemphigoid. Autoimmun Rev. 2022;21:103036.

  15. Carey B, Joshi S, Abdelghani A, Mee J, Andiappan M, Setterfield J. The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris. Br J Dermatol. 2020;182:747-53.

  16. Arduino PG, Porter SR. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37:107-21.

  17. Tandvårdens läkemedel 2022-2023. Råd och rekommendationer för läkemedelsanvändning inom tandvården. Available from: https://kunskapsstyrningvard.se/kunskapsstyrningvard/programomradenochsamverkansgrupper/nationellaprogramomraden/npotandvard/tandvardenslakemedel.62094.html

  18. Farmakoterapi vid herpes simplex-, varicella- och herpes zosterinfektioner - Behandlingsrekommendation Läkemedelsverket i samarbete med Referensgruppen för Antiviral Terapi (RAV). Information från Läkemedelsverket 4:2005:34-47, granskad 2018-12- 03.  [Available from: https://www.sls.se/globalassets/rav/rekommendationer/hsv-vzv-rek.pdf

  19. Lu SY. Oral Candidosis: Pathophysiology and Best Practice for Diagnosis, Classification, and Successful Management. J Fungi (Basel). 2021;7.

  20. Ariyawardana A, Chmieliauskaite M, Farag AM, Albuquerque R, Forssell H, Nasri-Heir C, et al. World Workshop on Oral Medicine VII: Burning mouth syndrome: A systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials. Oral Dis. 2019;25 Suppl 1:141-56.

  21. Wu S, Zhang W, Yan J, Noma N, Young A, Yan Z. Worldwide prevalence estimates of burning mouth syndrome: A systematic review and meta-analysis. Oral Dis. 2022;28:1431-40.

  22. Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: a systematic review of treatments. Oral Dis. 2018;24:325-34.

  23. McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev. 2016;11:Cd002779.

  24. Socialstyrelsen. Nationella riktlinjer för tandvård 2022 [Available from: https://www.socialstyrelsen.se/kunskapsstod-och-regler/regler-och-riktlinjer/nationella-riktlinjer/riktlinjer-och-utvarderingar/tandvard/

  25. Rekommendationer för antibiotikabehandling i tandvården. Information från Läkemedelsverket 2014;25(1):19–30.

  26. Eriksen HM. Epidemiology of apical periodontitits. In: Ørstavik D, Pitt Ford T, editors. Essential Endodontology. 2nd ed. Frederiksberg, Denmark: Blackwell Munksgaard Ltd; 2008. p. 267.

  27. Yu VS, Messer HH, Yee R, Shen L. Incidence and impact of painful exacerbations in a cohort with post-treatment persistent endodontic lesions. J Endod. 2012;38:41-6.

  28. Hallmer F, Andersson G, Götrick B, Warfvinge G, Anderud J, Bjørnland T. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126:477-85.

  29. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140:1238-44.

  30. Petti S, Glendor U, Andersson L. World traumatic dental injury prevalence and incidence, a meta-analysis-One billion living people have had traumatic dental injuries. Dent Traumatol. 2018;34:71-86.

  31. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80:920-43.

  32. Hong CHL, Hu S, Haverman T, Stokman M, Napenas JJ, Braber JB, et al. A systematic review of dental disease management in cancer patients. Support Care Cancer. 2018;26:155-74.

  33. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, et al. Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Supportive Care in Cancer. 2015;23:223-36.

  34. Schuurhuis JM, Span LF, Stokman MA, van Winkelhoff AJ, Vissink A, Spijkervet FK. Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy. Br J Cancer. 2016;114:972-8.

  35. Skallsjo K, Johansson JE, Jonasson P, Hasseus B. Apical periodontitis as potential source of infection in patients with lymphoma treated with chemotherapy. Clin Oral Investig. 2019.

  36. Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM, et al. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol. 2022;12:927685.

  37. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126:4423-31.

  38. Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, et al. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011;46:884-91.

  39. Gruter MO, Brand HS. Oral health complications after a heart transplant: a review. Br Dent J. 2020;228:177-82.

  40. Öhman J, Rexius H, Mjörnstedt L, Gonzalez H, Holmberg E, Dellgren G, et al. Oral and lip cancer in solid organ transplant patients--a cohort study from a Swedish Transplant Centre. Oral Oncol. 2015;51:146-50.

  41. Mougeot FK, Saunders SE, Brennan MT, Lockhart PB. Associations between bacteremia from oral sources and distant-site infections: tooth brushing versus single tooth extraction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:430-5.

  42. Wilson WR, Gewitz M, Lockhart PB, Bolger AF, DeSimone DC, Kazi DS, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021;143:e963-e78.

  43. Lockhart PB, DeLong HR, Lipman RD, Abt E, Baddour LM, Colvin M, et al. Effect of dental treatment before cardiac valve surgery: Systematic review and meta-analysis. J Am Dent Assoc. 2019;150:739-47.e9.

  44. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome). 2016;17:277-319.

  45. Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44:3948-4042.

  46. Indikationer för antibiotikaprofylax i tandvården – ny rekommendation. Information från Läkemedelsverket 2012;23(5):22–35  [Available from: https://www.lakemedelsverket.se/

  47. Topkan E, Kucuk A, Somay E, Yilmaz B, Pehlivan B, Selek U. Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors. J Clin Med. 2023;12.

  48. Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58:1373-7.

  49. Boromand G, Haugen-Cange H, Asparusova M, Ekestubbe A, Kjeller G. Long-term follow-up of osteoradionecrosis of the mandible. Acta Odontol Scand. 2024;82:48-54.

  50. Rekommendation för antibiotika till patienter som strålbehandlats mot munhålan. Tandläkartidningen. 2016.

  51. Götrick B, Akerman S, Ericson D, Torstenson R, Tobin G. Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res. 2004;83:393-7.

  52. Wallström MRV. Oral kirurgi av patienter med ökad blödningsrisk. Tandläkartidningen. 2012;104:70-4.

  53. Johansson K, Götrick B, Holst J, Tranæus S, Naimi-Akbar A. Impact of direct oral anticoagulants on bleeding tendency and postoperative complications in oral surgery: a systematic review of controlled studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;135:333-46.

  54. Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJ, van Galen KP. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev. 2018;7:Cd012293.

  55. Zaib A, Shaheryar M, Shakil M, Sarfraz A, Sarfraz Z, Cherrez-Ojeda I. Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2022;10.

  56. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976-82.

  57. Äldretandvård Ramdokument. Folktandvården Sverige. 2023.

  58. Nationellt kunskapsstöd för god palliativ vård i livets slutskede. 2013  [Available from: https://www.socialstyrelsen.se/kunskapsstod-och-regler/regler-och-riktlinjer/nationella-riktlinjer/riktlinjer-och-utvarderingar/palliativ-vard/

Föregående sida
Tandvård i livets slutskede

Nästa sida
Tillbaka till kapitlets första sida